Peptides in Your Serum vs. Peptides in a Vial: Two Categories, One Word

The word “peptide” is doing an enormous amount of work in the wellness market, and most of it is misleading.

A peptide is just a short chain of amino acids. That is the entire definition. It describes a structural class, not a function, a potency or a purpose — roughly the way “alcohol” describes both the ethanol in wine and the isopropyl in a first-aid kit.

The peptide in a thirty-dollar serum and the peptide in a vial from a research supplier share a naming convention. They do not share much else.

Four things called peptides

Four categories, four separate regulatory systems, one shared word. Nearly every confusion in this market traces back to that table.

Cosmetic peptides: a labeled ingredient, not a drug

Cosmetic peptides are formulated to sit on or in the upper layers of skin. Under US law, a cosmetic is a product intended to cleanse or beautify — and critically, a cosmetic cannot legally claim to alter the structure or function of the body. The moment it does, it is being marketed as a drug.

This is why the copy on a serum box reads the way it does. “Appears firmer,” “reduces the look of.” That hedging is not marketing cowardice; it is the boundary of the category.

What you can reasonably expect from a cosmetic peptide is modest, cumulative, and dependent on formulation, concentration and whether the molecule reaches the layer where its proposed mechanism operates. Penetration remains the central unresolved question in cosmetic peptide science.

Collagen peptides: a food, and mostly a protein

Collagen peptides are hydrolyzed collagen — long protein chains broken into shorter fragments so they dissolve and absorb more readily. They are regulated as a food or dietary supplement.

Here is the part that gets glossed: ingested collagen is digested. It is broken down into amino acids and small peptides, absorbed, and used wherever the body decides to use them. Drinking collagen does not deliver collagen to your skin the way a courier delivers a package to an address.

There is legitimate research on whether certain collagen-derived peptide fragments survive digestion in forms that signal to fibroblasts, and it is a real question rather than a marketing invention. But the mechanism is signaling, not delivery, and the effect sizes in the literature are modest.

Collagen peptides are also, functionally, a protein supplement with an incomplete amino acid profile — low in tryptophan. That is not a criticism, but it is worth knowing if you are counting it toward a protein target.

Approved peptide drugs: the category nobody counts

A number of peptides are fully approved prescription medications, and they demonstrate what the category can do when it goes through the full process.

Insulin is a peptide. Semaglutide and tirzepatide are peptides. Bremelanotide is a peptide — and notably, it is an approved melanocortin receptor agonist for a specific indication in women, which makes it a useful reference point when evaluating unapproved melanocortin compounds.

The relevant difference is not chemistry. It is that a sponsor ran clinical trials, submitted an application, and the FDA reviewed safety and effectiveness. Everything downstream — known dosing, characterized side effects, pharmacy dispensing, manufacturing standards — follows from that process.

Research peptides: the category with the missing infrastructure

This is where BPC-157, MOTS-c, Epitalon, TB-500 and the rest sit. They are sold labeled for research use only, explicitly not for human consumption, and that labeling is what keeps their sale lawful.

The July 2026 advisory vote concerned whether six of these could become eligible for pharmacy compounding. It did not make any of them approved drugs, and it did not change the status of research-use-only material in any way.

The substantive issue is characterization — knowing what is actually in the vial. That was the recurring technical objection FDA scientists raised across the July review, and it applies far more sharply to material sold outside the pharmacy system, where no one is required to check.

A field guide to the label

What the packaging tells you, if you read it as a category signal:

• “Appears firmer,” “reduces the look of” — cosmetic. Structure and function claims are off-limits by law.
• Supplement facts panel — food or dietary supplement. Sold without pre-market approval of effectiveness.
• Prescribing information, NDC number — approved drug. Reviewed for safety and effectiveness.
• “For research use only. Not for human consumption.” — research chemical. That sentence is a legal position, not a formality.

Why this matters practically

Because advice does not transfer across categories, and most of the advice circulating does not say which category it came from.

Storage guidance for a lyophilized research peptide has nothing to say about your serum. Safety considerations for a subcutaneous compound do not apply to collagen powder. And a regulatory headline about one category will be marketed as validation of a completely different one — which is exactly what happened after July, and exactly what will happen again after February.